Minimally Invasive Surgery Industry Outlook (2022-2032)

The global minimally invasive surgery market is likely to be valued at US$ 6.31 Billion in FY 2022, up from US$ 6 Billion in 2021.

Demand for orthopedic surgery will continue to thrive, with a documented CAGR of 4% during the 2015-2021 historical period of assessment, hospitals & clinics remained the primary site for minimally invasive surgical procedures, proliferating at a rate of 5.1% during the same period.

Request For Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=5780

Key Segments Covered in the Minimally Invasive Surgery Industry Survey

• Minimally Invasive Surgery by Procedure :

  • Minimally Invasive Laparoscopic Surgery
  • Minimally Invasive Robotic Surgery
  • Minimally Invasive Endoscopic Mucosal Resection
  • Minimally Invasive Endoscopic Sub-Mucosal Dissection

• Minimally Invasive Surgery by End User :

  • Minimally Invasive Surgery at Hospitals
  • Minimally Invasive Surgery at Clinics
  • Minimally Invasive Surgery at Ambulatory Surgical Centres
  • Minimally Invasive Surgery by Other End Users

• Minimally Invasive Surgery by Disorder Type :

  • Orthopedic Minimally Invasive Surgery
  • Cosmetic & Bariatric Minimally Invasive Surgery
  • Gynaecological Minimally Invasive Surgery
  • Cardiothoracic Minimally Invasive Surgery
  • Gastrointestinal Minimally Invasive Surgery
  • Urological Minimally Invasive Surgery
  • Minimally Invasive Surgery for Other Disorder

• Minimally Invasive Surgery by Region :

  • North America Minimally Invasive Surgery Market
  • Latin America Minimally Invasive Surgery Market
  • Europe Minimally Invasive Surgery Market
  • Asia Pacific Minimally Invasive Surgery Market
  • The Middle East & Africa Minimally Invasive Surgery Market

Competitive Landscape

Prominent Minimally Invasive Surgery providers are reliant on partnerships, collaborations, acquisitions, and new software launch to stay afloat in the global market. Constant innovations to ensure a seamless client-customer relationship are the main focus of prominent market players.

• In March 2019, the University of Pittsburgh Medical Centre firstly adopted RAMIE (Robot-Assisted Minimally Invasive Esophagectomy) Program and yielded excellent outcomes with increasing proficiency throughout the learning curve.
• In February 2019, Huntington Hospital completed the acquisition of two da Vinci Xi Surgical Systems, the next generation in robotic surgical equipment. The da Vinci Xi System was designed to further advance the technology used in minimally invasive surgery, used across a spectrum of minimally invasive surgical procedures in gynaecology, urology, thoracic, colorectal, and general surgery.